Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

Vitiligo is an acquired chronic depigmenting disorder of the skin, with an estimated
prevalence of 0.5% of the general population, characterized by the development of white …

Vitamin D plays a key role in skeletal and cardiovascular disorders, cancers, central nervous
system diseases, reproductive diseases, infections, and autoimmune and dermatological …

The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo,
early factors include activation of innate immunity, inflammasome activation, oxidative stress …

Importance Surgical interventions are a key part of the therapeutic arsenal, especially in
refractory and stable vitiligo. Comparison of treatment outcomes between the different …

Background: Scientific rationale and encouraging first clinical results suggest the interest of
using apremilast for treating vitiligo. Objective: This study aimed to compare the efficacy of …

Vitiligo is an acquired pigmentary disorder afflicting 0.5-2% of the world population for both
sexes and all races with a capricious and unpredictable course. It has a complex etiology …

Background Topical calcineurin inhibitors are used off label in the treatment of vitiligo, and
there is a lack of placebo-controlled, blinded studies to support their use. Objective This …

Background Vitiligo can be challenging to treat and exhibit an unpredictable clinical course.
Phototherapy in the form of visible light can achieve both repigmentation and …